Indicadores financieros
- Market Capitalization 1.46 B
- Employee 524
- Founded 2008
- CEO Bahija Jallal
- Website www.immunocore.com
- Headquarter United Kingdom
- FIGI BBG00YYCXFB9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-48.89
Relación precio/flujo de caja
4.37
Tickers relacionados
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2146 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 14.81 USD | -0.74% | -0.60% | +9.14% | -53.38% | 1.46 B USD | ||
| 2151 | STOK Stoke Therapeutics, Inc. - Common Stock | 22.74 USD | +1.07% | -7.94% | -23.07% | -34.95% | 1.47 B USD | ||
| 2175 | AAPG Ascentage Pharma Group International - American Depository Shar | 15.06 USD | -1.63% | +1.14% | -5.87% | -39.76% | 1.41 B USD | ||
| 2184 | OMER Omeros Corporation - Common Stock | 19.03 USD | +0.79% | +2.26% | +10.25% | +64.19% | 1.38 B USD |